Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA.
Radiother Oncol. 2011 Apr;99(1):49-54. doi: 10.1016/j.radonc.2011.01.025. Epub 2011 Mar 22.
The purpose of this study was to design a radiation therapy treatment planning approach that would spare hematopoietically active bone marrow using [(18)F]FLT PET imaging.
We have developed an IMRT planning methodology to incorporate functional PET imaging using [(18)F]FLT scans. Plans were generated for two simulated cervical cancer patients, where pelvic active bone marrow regions were incorporated as avoidance regions based on the ranges: SUV4 ≥ 4; 4>SUV3 ≥ 3; and 3 > SUV2 ≥ 2. Dose objectives were set to reduce bone marrow volume that received 10 (V(10)) and 20 (V(20))Gy.
Active bone marrow regions identified by [(18)F]FLT with an SUV ≥ 2, SUV ≥ 3, and SUV ≥ 4 represented an average of 43.0%, 15.3%, and 5.8%, respectively of the total osseous pelvis for the two cases studied. Improved dose-volume histograms for all identified bone marrow SUV volumes and decreases in V(10), and V(20) were achieved without clinically significant changes to PTV or OAR doses.
Incorporation of [(18)F]FLT PET in IMRT planning provides a methodology to reduce radiation dose to active bone marrow without compromising PTV or OAR dose objectives in pelvic malignancies.
本研究旨在设计一种放射治疗计划方法,通过 [(18)F]FLT PET 成像来保护造血活跃的骨髓。
我们已经开发了一种 IMRT 计划方法,以整合使用 [(18)F]FLT 扫描的功能 PET 成像。为两个模拟的宫颈癌患者生成了计划,其中根据 SUV4≥4;4>SUV3≥3;和 3>SUV2≥2 的范围,将骨盆活跃的骨髓区域纳入回避区域。剂量目标设定为减少接受 10(V(10))和 20(V(20))Gy 的骨髓体积。
[(18)F]FLT 识别的活跃骨髓区域,SUV≥2、SUV≥3 和 SUV≥4 分别代表两个研究病例的总骨盆骨的平均 43.0%、15.3%和 5.8%。所有识别的骨髓 SUV 体积的剂量-体积直方图得到改善,V(10)和 V(20) 减少,而 PTV 或 OAR 剂量没有明显变化。
在 IMRT 计划中纳入 [(18)F]FLT PET 提供了一种方法,可以在不影响骨盆恶性肿瘤的 PTV 或 OAR 剂量目标的情况下,降低活跃骨髓的辐射剂量。